Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Prediction of Emerging CVD Biomarkers in Population Exposed to Arsenic and Their Associated Risk Factors in Humans by
Noorul Izzati Hanafi1, Mohd Hafiz Dzarfan Othman2, Siti Hamimah Sheikh Abdul Kadir3,4
1Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Campus Sungai Buloh, Jalan Hospital, Sungai Buloh, 47000, Selangor, Malaysia.
None:
Arsenic is a natural compound of metalloid (both metal and non-metal) found in soil and minerals used in semiconductor and alloys. Arsenic exposure is associated with an increased risk of cardiovascular disease (CVD) risk from drinking water or environmental sources. Exploring the emerging biomarkers associated with CVD upon arsenic exposure is crucial. Thus, this review paper aimed to analyze the prediction of emerging CVD biomarkers in population exposed to arsenic and their associated risk factors in humans by a systematic review and meta-analysis. A systematic search was conducted using PubMed, Scopus, and Web of Science to identify eligible studies on arsenic exposure associated with CVDs and their risk factors. Sensitivity, specificity, and predictive value of biomarkers for CVD of arsenic exposed population were assessed by calculating the quality criteria, standard means different (SMD), odds ratio (OR), and 95% confidence intervals (CIs). A meta-analysis was used to derive a combined SMD and OR for the heterogeneity test in between studies. The meta-analysis of nine articles were included. The overall effect sizes revealed significant heterogeneity across studies (I2 = 97.57%), with pooled effect size was 3.578 (95% CI 3.032 to 4.123, p < 0.0001) under the random-effects model. These results indicate a robust association between arsenic exposure and adverse cardiovascular outcomes, as confirmed by sensitivity analyses and bias assessments (Systematic review registration: PROSPERO CRD42024616848). To improve the quality of future research, efforts should concentrate on enhancing control for confounders, enrolling diverse participant populations, and implementing and yield more substantial findings concerning the cardiovascular effects of arsenic exposure.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
07:35Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Related Concept Videos
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis II: Clinical manifestations and prevention
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...